Fresenius | FRE - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Akzo Nobel EUR 171.41M 100K 2026-06
Alcon AG USD 487.4M 0 2026-06
AstraZeneca USD 1.55B 44K 2026-06
BASF EUR 884.32M 8.2M 2026-06
Bayer EUR 982.42M 0 2026-06
Beiersdorf EUR 218.92M 1.29M 2025-12
DaVita Healthcare Partners USD 63.96M 2.23M 2026-06
Demant DKK 210.9M 5.18M 2025-12
E.ON EUR 2.61B 0 2026-06
Essilor EUR 463.19M 144.06K 2026-06
Fresenius EUR 563.24M 0 2026-06
Fresenius Medical Care EUR 266.11M 3.98M 2026-06
Getinge SEK 272.37M 136.37M 2026-06
Givaudan CHF 9.23M 0 2025-12
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
GN Store Nord DKK 145.61M 0 2026-06
GRIFOLS EUR 680.58M 6K 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2026-06
Novartis USD 1.9B 7.38M 2026-06
Philips EUR 952.02M 729K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
RWE EUR 779.98M 66.42M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Smith & Nephew USD 875.95M 11.64K 2026-06